Theo-24 Cr
Theo-24 Cr Price range: $ 44,00 through $ 103,00
Back to products
Tinidazole
Tinidazole Price range: $ 51,00 through $ 267,00

Thorazine

Price range: $ 47,00 through $ 161,00

Thorazine is a highly effective phenothiazine medication primarily used to manage symptoms of schizophrenia and the manic phase of bipolar disorder. It also serves as a reliable option for treating severe behavioral problems in children, including hyperactivity and combativeness. In addition to its psychiatric applications, this medication is officially indicated for the relief of persistent hiccups. Patients may also utilize it to alleviate severe nausea and vomiting across various medical settings. Finally, Thorazine is frequently administered to reduce restlessness and apprehension in individuals prior to undergoing surgery.

Active substance: Chlorpromazine
SKU: Thorazine Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Thorazine belongs to a class of medications known as phenothiazine antipsychotics, functioning primarily as a central dopamine receptor antagonist. It is a prescription medication utilized in clinical practice for managing manifestations of psychotic disorders, severe nausea, intractable hiccups, and specific acute medical conditions. Due to its complex pharmacodynamic profile, treatment requires careful medical supervision and individualized dosage titration.

Dispensed strictly under federal and state regulations by prescription, Thorazine requires comprehensive patient monitoring to evaluate clinical response and mitigate potential adverse events. Understanding its mechanism, interaction profile, and administrative guidelines is essential for safe therapeutic outcomes.

Parameter Details
Active ingredient Chlorpromazine hydrochloride
Therapeutic class Phenothiazine antipsychotic (conventional neuroleptic)
Dosage form Oral tablets, oral concentrate, injectable solution
Route of administration Oral, Intramuscular, Intravenous
Prescription status Prescription only (Rx)
Primary purpose Management of psychotic disorders, severe nausea, and hiccups

Thorazine Prescribing Guidelines and Clinical Features

How the drug works

Thorazine (chlorpromazine) exerts its therapeutic effects predominantly through the blockade of postsynaptic dopamine D2 receptors in the mesolimbic and nigrostriatal pathways of the brain. Inhibiting dopaminergic transmission helps alleviate hallucinations, delusions, and severe agitation associated with psychotic states. In addition to dopamine blockade, chlorpromazine possesses significant antagonist activity at histaminergic H1 receptors, alpha-1 adrenergic receptors, and muscarinic acetylcholine M1 receptors. The blockade of dopamine receptors in the chemoreceptor trigger zone (CTZ) of the medulla accounts for its potent antiemetic properties, while peripheral alpha-adrenergic blockade contributes to vascular effects such as orthostatic hypotension.

Main uses

Thorazine is indicated for several distinct medical conditions approved by the U.S. Food and Drug Administration (FDA). Its primary psychiatric indication includes the management of manifestations of psychotic disorders and the control of the manic phase of bipolar disorder. In general medicine, it is indicated for the control of severe nausea and vomiting in adults, the relief of restlessness and apprehension prior to surgery, and as an adjunct in the treatment of tetanus. Furthermore, chlorpromazine is approved for the treatment of intractable hiccups–defined as persistent hiccups continuing for more than 48 hours. Any use outside of these official FDA-labeled indications, such as off-label management of insomnia or generalized anxiety, requires specific medical justification by a licensed healthcare provider.

Dosing schedule

Dosage of Thorazine must be individualized based on the specific condition being treated, severity of symptoms, and patient response. For oral administration in adult psychotic disorders, treatment typically starts at lower daily dosages, gradually titrated upward under direct medical supervision until therapeutic control is achieved. For intractable hiccups, oral dosages are administered several times daily for several days; if symptoms persist, parenteral therapy may be evaluated by the prescriber. Pediatric dosages are calculated strictly based on body weight or age and should never exceed adult thresholds. Patients must adhere strictly to the schedule prescribed by their healthcare provider and never adjust doses independently.

How it’s absorbed and eliminated

Following oral administration, chlorpromazine is absorbed through the gastrointestinal tract, though it undergoes extensive first-pass hepatic metabolism, resulting in variable systemic bioavailability. Plasma concentration peaks within several hours after ingestion. The drug is highly bound to plasma proteins, predominantly albumin, and distributes widely throughout body tissues, including crossing the blood-brain barrier. Chlorpromazine is extensively metabolized in the liver via cytochrome P450 enzymes (including CYP2D6) into numerous active and inactive metabolites. Elimination occurs primarily through renal excretion of metabolites in urine, with a portion excreted via the biliary system into feces. The elimination half-life varies significantly among individuals due to metabolic diversity.

What you may notice early on

During the initial phase of treatment with Thorazine, patients frequently experience marked sedation or drowsiness as the central nervous system adjusts to H1 receptor blockade. Dizziness or lightheadedness upon standing up quickly may occur due to alpha-adrenergic receptor inhibition causing temporary blood pressure drops. Dry mouth, blurred vision, and mild nasal congestion are common early anticholinergic effects. Reduction in acute agitation or psychotic distress may occur within hours to days, whereas full stabilization of thought processes often requires several weeks of consistent therapy.

Adverse reactions

Chlorpromazine therapy carries a risk of neurological, cardiovascular, and autonomic side effects. Neurological effects include extrapyramidal symptoms (EPS) such as acute dystonia (involuntary muscle contractions), akathisia (motor restlessness), and pseudoparkinsonism (tremor, rigidity, bradykinesia). Prolonged administration increases the risk of tardive dyskinesia, a potentially irreversible syndrome characterized by involuntary, repetitive movements of the face, tongue, or extremities. Autonomic and endocrine adverse effects include dry mouth, urinary retention, severe constipation, hyperprolactinemia (which may cause gynecomastia or galactorrhea), weight gain, and photosensitivity reactions resulting in severe sunburn upon light exposure.

Red flags

Certain adverse events associated with Thorazine require immediate emergency evaluation. Patients and caregivers must remain vigilant for severe neurological and systemic reactions that signal life-threatening complications.

Warning Sign / Symptom Potential Medical Condition Immediate Action
High fever, severe muscle stiffness, confusion, irregular pulse Neuroleptic Malignant Syndrome (NMS) Seek emergency medical care immediately
Uncontrolled, rhythmic movements of the tongue, face, mouth, or jaw Tardive Dyskinesia Contact prescriber urgently
Sore throat, sudden fever, chills, unusual weakness Agranulocytosis / Leukopenia Obtain emergency blood work evaluation
Swelling of face, lips, tongue, or severe breathing difficulty Severe allergic reaction (Anaphylaxis) Call 911 or visit emergency room
Yellowing of the skin or eyes (jaundice), dark urine Hepatic dysfunction / Cholestatic jaundice Seek prompt medical attention

Compatibility with other medicines

Thorazine exhibits significant drug interactions due to its broad pharmacological profile. Co-administration with central nervous system depressants–including opioids, benzodiazepines, barbiturates, and sedating antihistamines–can cause severe respiratory depression and profound sedation. Combining chlorpromazine with antihypertensive agents may potentiate hypotensive effects. Medications that prolong the QT interval (such as certain antiarrhythmics, macrolide antibiotics, or other antipsychotics) increase the risk of ventricular arrhythmias when taken concurrently. Agents with anticholinergic properties may worsen constipation, urinary retention, and cognitive impairment. Concomitant use of CYP2D6 inhibitors may elevate chlorpromazine plasma levels, increasing toxicity risks.

What to avoid while taking it

Patients receiving Thorazine must completely avoid consuming alcohol, as ethanol significantly intensifies central nervous system depression and impairs cognitive and motor functions. Direct exposure to sunlight or ultraviolet radiation should be minimized; chlorpromazine causes photosensitization, making skin exceptionally susceptible to severe sunburns. Protective clothing, sunglasses, and broad-spectrum sunscreen are recommended during outdoor activities. Avoid strenuous exercise in hot environments, as the medication impairs the body’s ability to regulate core body temperature, raising the risk of heatstroke.

Important precautions

Boxed Warning: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Thorazine is not approved for the treatment of patients with dementia-related psychosis.

Caution is warranted in patients with pre-existing cardiovascular disease, hepatic impairment, seizure disorders, glaucoma, or prostatic hypertrophy. Phenothiazines lower the seizure threshold; thus, patients with a history of epilepsy require close monitoring. During pregnancy, Thorazine should be used only if the potential benefit justifies the potential risk to the fetus; third-trimester exposure carries a risk of extrapyramidal or withdrawal symptoms in newborns. Chlorpromazine passes into breast milk, requiring clinical guidance regarding infant feeding safety.

Storage and expiration

Thorazine tablets and liquid formulations should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), away from excessive heat, moisture, and direct light. Keep liquid preparations in light-resistant containers. Do not store this medication in humid environments such as bathroom cabinets. Keep all formulations out of the reach and sight of children and pets. Safely discard any medication that has passed its expiration date according to local pharmaceutical disposal guidelines.

Common questions

Can Thorazine cause extreme sensitivity to sunlight?

Yes. Thorazine is known to cause photosensitivity, a reaction where the skin becomes abnormally sensitive to ultraviolet light. Exposure to sunlight even for short periods can lead to severe sunburn, rash, or skin discoloration. Patients taking chlorpromazine are advised to wear protective clothing, apply broad-spectrum sunscreen, and limit direct exposure to natural or artificial sunlight.

Can Thorazine be stopped suddenly after long-term use?

Abrupt cessation of Thorazine after prolonged administration is not recommended. Sudden discontinuation can precipitate withdrawal symptoms, including nausea, vomiting, dizziness, tremors, and a return of underlying psychotic or behavioral symptoms. Dosage reduction should always be conducted gradually under the direct guidance of the prescribing physician.

How does Thorazine treat severe, non-stop hiccups?

While the exact pathway is complex, Thorazine is thought to interrupt persistent hiccups by inhibiting dopamine transmission in the brainstem centers that control the hiccup reflex arc and by relaxing diaphragmatic spasms. It is reserved for intractable hiccups that have persisted for more than 48 hours and have failed to respond to simpler interventions.

What should be done if involuntary muscle movements develop?

If involuntary movements of the face, tongue, jaw, arms, or legs occur, contact your healthcare provider promptly. These may represent extrapyramidal side effects or early signs of tardive dyskinesia. Early clinical assessment is critical, as prescribers may need to adjust the dosage, discontinue the drug, or switch to an alternative agent.

Is Thorazine safe during pregnancy?

Thorazine should only be used during pregnancy if explicitly prescribed by a doctor who has weighed the clinical benefits against potential risks. Administering phenothiazines during the third trimester may cause extrapyramidal signs or withdrawal symptoms in newborns, requiring careful neonatal observation post-delivery.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

50mg

,

100mg

Package

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία